VTVT
vTv Therapeutics Inc
30.70$
+0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,987.0% | -7,118.7% | -7,603.9% | -15,312.7% | -216.0% | -832.8% | -280.6% | -482.1% | -755.5% | -212,011.1% | -2,488.4% | – | |
| 55.8% | 96.5% | 41.8% | 67.7% | 1.8% | 1.4% | 1.5% | 2.2% | 4.6% | 1,000.0% | 8.8% | – | |
| – | 165.5% | 416.6% | 1,252.6% | 21.5% | 54.9% | 15.7% | 58.8% | 63.0% | 17,533.3% | 271.1% | – | |
| 79.0% | -2,310.2% | -5,735.3% | -11,917.2% | 21.4% | 44.5% | 15.7% | -160.9% | 223.2% | – | – | – | |
| -108.7% | 393.3% | 644.5% | 1,730.9% | -60.7% | -74.3% | -42.2% | 0.9% | 266.8% | 48,822.2% | -534.7% | – | |
| 2.1% | 20.0% | 13.7% | 19.6% | 0.0% | 2.5% | 0.3% | 0.5% | 1.0% | 0.0% | 0.0% | – | |
| 10.4% | -15.2% | -13.1% | -8.6% | 0.1% | 8.8% | -0.3% | -0.5% | -1.0% | 48,933.3% | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | 35.9% | – | – | – | – | – | – | |
| -161.4% | 20,380.2% | 145.6% | 103.8% | 172.9% | 35.9% | 224.9% | – | 483.0% | – | – | – | |
| 2,157.1% | 3,699.4% | 1,966.4% | 2,577.3% | -39.3% | -364.4% | -77.3% | 4.3% | -1.6% | -366.7% | -18.8% | – | |
| 1,995.7% | 23,823.5% | 1,860.3% | 2,577.3% | 133.6% | 827.4% | 303.6% | 673.6% | 692.7% | 133,300.0% | 5,172.8% | – | |
| 19.0% | 16,689.6% | -5,756.8% | -12,744.0% | -82.3% | 3.4% | 22.9% | 191.5% | -63.9% | -29,777.8% | 2,684.4% | – | |
| -1,989.2% | -7,138.7% | -7,617.7% | -15,332.3% | -216.0% | -835.3% | -280.6% | -482.1% | -756.5% | -212,011.1% | -2,488.4% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.